1. Home
  2. TBPH vs RWT Comparison

TBPH vs RWT Comparison

Compare TBPH & RWT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TBPH
  • RWT
  • Stock Information
  • Founded
  • TBPH 2013
  • RWT 1994
  • Country
  • TBPH United States
  • RWT United States
  • Employees
  • TBPH N/A
  • RWT N/A
  • Industry
  • TBPH Biotechnology: Pharmaceutical Preparations
  • RWT Real Estate Investment Trusts
  • Sector
  • TBPH Health Care
  • RWT Real Estate
  • Exchange
  • TBPH Nasdaq
  • RWT Nasdaq
  • Market Cap
  • TBPH 699.0M
  • RWT 734.0M
  • IPO Year
  • TBPH N/A
  • RWT 1995
  • Fundamental
  • Price
  • TBPH $18.81
  • RWT $5.39
  • Analyst Decision
  • TBPH Strong Buy
  • RWT Buy
  • Analyst Count
  • TBPH 4
  • RWT 8
  • Target Price
  • TBPH $24.25
  • RWT $7.00
  • AVG Volume (30 Days)
  • TBPH 569.5K
  • RWT 1.2M
  • Earning Date
  • TBPH 11-10-2025
  • RWT 10-29-2025
  • Dividend Yield
  • TBPH N/A
  • RWT 13.36%
  • EPS Growth
  • TBPH N/A
  • RWT N/A
  • EPS
  • TBPH 0.58
  • RWT N/A
  • Revenue
  • TBPH $80,327,000.00
  • RWT $120,897,000.00
  • Revenue This Year
  • TBPH $79.82
  • RWT N/A
  • Revenue Next Year
  • TBPH N/A
  • RWT $30.20
  • P/E Ratio
  • TBPH $32.54
  • RWT N/A
  • Revenue Growth
  • TBPH 27.12
  • RWT N/A
  • 52 Week Low
  • TBPH $7.90
  • RWT $4.68
  • 52 Week High
  • TBPH $18.96
  • RWT $7.29
  • Technical
  • Relative Strength Index (RSI)
  • TBPH 68.84
  • RWT 54.53
  • Support Level
  • TBPH $17.50
  • RWT $5.00
  • Resistance Level
  • TBPH $18.58
  • RWT $5.18
  • Average True Range (ATR)
  • TBPH 0.99
  • RWT 0.13
  • MACD
  • TBPH 0.16
  • RWT 0.03
  • Stochastic Oscillator
  • TBPH 98.49
  • RWT 100.00

About TBPH Theravance Biopharma Inc.

Theravance Biopharma Inc is a diversified biopharmaceutical company focused on the discovery, development, and commercialization of organ-selective medicines. Its purpose is to pioneer a new generation of small-molecule drugs designed to meet patient needs. Its research is focused on the areas of inflammation and immunology. The firm applies organ-selective expertise to target disease biologically, to discover and develop medicines that may expand the therapeutic index with the goal of maximizing efficacy and limiting systemic side effects. The company develops lung-selective medicines to treat respiratory disease, including FDA-approved YUPELRI (revefenacin) inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).

About RWT Redwood Trust Inc.

Redwood Trust Inc is a real estate investment trust focused on different areas of housing credit. The company operates in three segments: Sequoia Mortgage Banking includes mortgage loan conduit that acquires residential consumer loans from third-party originators for sale to whole loan buyers and securitization; CoreVest Mortgage Banking segment includes consists of a platform that originates residential investor loans for securitization, sale, or transfer into Redwood Investments portfolio; and Redwood Investments segment consists of organic investments sourced through mortgage banking operations, including securities retained from Sequoia and CoreVest securitization activities. It derives maximum revenue from Redwood Investments segment.

Share on Social Networks: